March 25, 2020 / 12:41 PM / 3 days ago

Obalon Therapeutics explores strategic alternatives as coronavirus hits

March 25 (Reuters) - Obalon Therapeutics said on Wednesday it was exploring financial and strategic alternatives due to the uncertainty regarding COVID-19 and restriction on elective procedures, which have had a direct impact on its business.

The company has engaged Canaccord Genuity LLC as its financial advisor. (Reporting by Trisha Roy in Bengaluru; Editing by Vinay Dwivedi)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below